celastrol has been researched along with Bladder Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chadalapaka, G; Jutooru, I; Safe, S | 1 |
1 other study(ies) available for celastrol and Bladder Cancer
| Article | Year |
|---|---|
Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
Topics: Animals; Cell Line, Tumor; Female; Humans; Mice; Mice, Nude; Pentacyclic Triterpenes; Receptor, Fibroblast Growth Factor, Type 3; Sp Transcription Factors; Triterpenes; Urinary Bladder Neoplasms | 2012 |